查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523300

药物释放型支架市场报告：2030 年趋势、预测与竞争分析

Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药物释放型支架的趋势与预测

预计到 2030 年，全球药物释放型支架市场将达到 128 亿美元，2024 年至 2030 年复合年增长率为 6.3%。该市场的主要驱动因素是全球老年人口的增加和心血管疾病发生率的上升。全球药物释放型支架市场的未来充满希望，冠状动脉疾病和周边动脉疾病市场存在着机会。

药物释放型支架按细分市场

该研究包括按涂层类型、应用和地区对全球药物释放型支架市场的预测。

药物释放型支架市场洞察

Lucintel 预测，由于其经过验证的有效性和适应性，聚合物基涂料在预测期内将继续成为更大的细分市场。

在这个市场中，由于冠状动脉疾病的全球盛行率不断增加，冠状动脉疾病将继续占据很大一部分。

由于其发达的医疗基础设施和先进医疗技术的广泛采用，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场规模为：

A1. 到2030年，全球药物释放型支架市场预计将达到128亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球药物释放型支架市场预计将以6.3%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动因素是全球老年人口的增加和心血管疾病发生率的上升。

Q4.市场的主要细分市场是：

A4.药物释放型支架市场前景广阔，冠状动脉疾病和周边动脉疾病市场充满机会。

Q5.市场的主要企业是：

A5.主要的药物释放型支架公司如下：

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，在预测期内，基于聚合物的涂料将继续成为一个更大的细分市场，因为它已经证明了其有效性和适应性。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于其发达的医疗基础设施和先进医疗技术的广泛采用，北美在预测期内仍然是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球药物释放型支架市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球药物释放型支架市场趋势（2018-2023）与预测（2024-2030）
  • 按涂层类型分類的全球药物释放型支架市场
    • 聚合物基涂料
    • 无聚合物涂层
  • 按应用分列的全球药物释放型支架市场
    • 冠状动脉疾病
    • 周边动脉疾病

第四章 2018-2030年区域市场趋势及预测分析

  • 全球药物释放型支架市场区域分布
  • 北美药物释放型支架市场
  • 欧洲药物释放型支架市场
  • 亚太地区药物释放型支架市场
  • 其他地区药物释放型支架市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球药物释放型支架市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球药物释放型支架市场产能
    • 全球药物释放型支架市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun
简介目录

Drug-Eluting Stent Trends and Forecast

The future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug-Eluting Stent by Segment

The study includes a forecast for the global drug-eluting stent by coating type, application, and region.

Drug-Eluting Stent Market by Coating Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polymer-Based Coating
  • Polymer-Free Coating

Drug-Eluting Stent Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Drug-Eluting Stent Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug-Eluting Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug-eluting stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Drug-Eluting Stent Market Insights

Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Within this market, coronary artery disease will remain larger segment due to increasing global incidence of coronary artery disease.

North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Features of the Global Drug-Eluting Stent Market

Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).

Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug-eluting stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug-eluting stent market size?

Answer: The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030.

Q2. What is the growth forecast for drug-eluting stent market?

Answer: The global drug-eluting stent market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug-eluting stent market?

Answer: The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

Q4. What are the major segments for drug-eluting stent market?

Answer: The future of the drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets.

Q5. Who are the key drug-eluting stent market companies?

Answer: Some of the key drug-eluting stent companies are as follows:

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Q6. Which drug-eluting stent market segment will be the largest in future?

Answer: Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Q7. In drug-eluting stent market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug-Eluting Stent Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug-Eluting Stent Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug-Eluting Stent Market by Coating Type
    • 3.3.1: Polymer-Based Coating
    • 3.3.2: Polymer-Free Coating
  • 3.4: Global Drug-Eluting Stent Market by Application
    • 3.4.1: Coronary Artery Disease
    • 3.4.2: Peripheral Artery Disease

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug-Eluting Stent Market by Region
  • 4.2: North American Drug-Eluting Stent Market
    • 4.2.1: North American Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.2.2: North American Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.3: European Drug-Eluting Stent Market
    • 4.3.1: European Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.3.2: European Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.4: APAC Drug-Eluting Stent Market
    • 4.4.1: APAC Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.4.2: APAC Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.5: ROW Drug-Eluting Stent Market
    • 4.5.1: ROW Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.5.2: ROW Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
    • 6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
    • 6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
  • 6.2: Emerging Trends in the Global Drug-Eluting Stent Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific
  • 7.2: Medtronic
  • 7.3: Abbott Laboratories
  • 7.4: Biosensors
  • 7.5: Biotronik
  • 7.6: Lepu Medical Technology
  • 7.7: Terumo Medical
  • 7.8: Cook Medical
  • 7.9: Shandong JW Medical Systems
  • 7.10: B.Braun